NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Juniper Biomedical

Juniper Biomedical

Private
Worcester, MassachusettsHealthcare & Life Scienceshttps://www.juniperbiomedical.com/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$4.6M

Company Overview

Juniper Biomedical is a medical device company that develops implantable neuromodulation systems to treat pelvic health conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationimplantable medical devicepelvic healthnerve stimulationbioelectronic medicineurinary incontinencebowel incontinencepelvic painminimally invasivemicro-neuromodulatormedtechimplantable techperipheral nerve stimulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juniper Biomedical Comps

Public and private peers based on sector, stage, and business model.

Juniper Biomedical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Juniper Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
SeedApr 2, 2024
GrantApr 2, 2024

Key People

Founding team and executive leadership

Mario Romero-Ortega

Co-Founder and Chief Scientific Officer

Founding Team

David N Constantine

Co-Founder & CEO

Founding Team

Gregory Martin

Chief Technology Officer

Executive Team

Jayme Coates

Chief Operating Officer

Executive Team

Juniper Biomedical Investors

Notable investors and investment history

Juniper Biomedical investors
InvestorRounds
NIH RADxGrant
Beacon AngelsSeed
Hub Angels Investment GroupSeed
Atma CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 40% MoM.

  • Jan 20, 2026

    Monthly visitors grew 95% MoM.

Juniper Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Juniper Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Juniper Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWorcester, Massachusetts
Employee Range9
Year Founded2019
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.